Pay in 4 interest-free payments of $6.27 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
20 Semaglutide demonstrated promising efficacy in glycemic control and weight loss compared with placebo and active comparators such as insulin glargine, sitagliptin, dulaglutide and exenatide sustained-release
Wang Y, Sharma RK, Falcone T, Goldberg J, Agarwal A
HbA1c and Body Weight Across the five global phase 3 SURPASS studies, which spanned the T2D disease continuum from no background therapy to multiple background treatment combinations, and included several comparators representative of clinical practice, administration of all tirzepatide doses (5, 10 and 15 mg) led to consistent improvements in glycaemic control, as shown by reductions in HbA1c from baseline to 40 or 52 weeks (Table 2) [4,5,6,7,8]
Ozempic vs Wegovy vs Rybelsus: Key Differences (Form, Dose, Strength & Uses) How does semaglutide work
